Welcome to LookChem.com Sign In|Join Free

Hefei TNJ chemical industry co.,ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
10th
years
Home>>Products>>Enrofloxacin with high quality and reasonable price

Product Certification&
Enterprise Certification

More Detail

Hefei TNJ chemical industry co.,ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Sophia Zhang

Tel: +86-551-65418695

Ms.Rainie Wong

Tel: 0086-551-65418671

Ms.Dory Wong

Tel: 0086-551-67199489

Ms.Bella Tao

Tel: 0551-65418672

Mr.Eric

Tel: +86 551 6541 8675

Ms.Jessie Hwang

Tel: +86-551-65418676

Mr.Will

Tel: 0551-65418684

Ms.Grace Du

Tel: 0086-551 65418681

Mr.Sean Jiang

Tel: 055165418684

Ms.Betty Fang

Tel: 0086-551-65418684

Mr.Bruce Zhang

Tel: 0086 551-67199490

Mobile: 0086-551-18225849144

Tel: +86-551-65418695

Fax: +86-51-65418697

URL: https://www.tnjchem.com

Province/state: Anhui

City: Hefei

Street: B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China

MaxCard:


qq Contact Suppliers

Enrofloxacin with high quality and reasonable price

CAS NO.93106-60-6

Contact Supplier

Product Details

Keywords

  • Enrofloxacin
  • 93106-60-6
  • Enrofloxacin base

Quick Details

  • ProName: Enrofloxacin with high quality and rea...
  • CasNo: 93106-60-6
  • Molecular Formula: C19H22FN3O3
  • Appearance: White or light yellow crystalline acic...
  • Application: Used as a beast with antibacterial dru...
  • DeliveryTime: within 7 days after confirm payment
  • PackAge: 25kg/drum or according to your require...
  • Port: main ports in China
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99%
  • Storage: Storage: All products should be stored...
  • Transportation: by sea or by air
  • LimitNum: 0 Metric Ton

Superiority

Poultry enrofloxacin

1. Basic information

Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine 

Appearance: Light-yellow or light-yellow orange crystalline powder

Purity: 99% min

2.Introduction 

Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

3.Specification 

Item

Standard

Result

Appearance

Light-yellow or light-yellow orange crystalline powder

Light-yellow crystalline Powder

Melting range

Between 221°C and 226°C

223.0°C~225.5°C

Identification

Meet the requirements

Meet the requirements

Fluoroquinolonic acid

Not more than 0.2%

<0.2%

Ciprofloxacin

Not more than 1.0%

0.15%

Loss on drying

Not more than 3.0%

0.1%

Residue on ignition

Not more than 0.2%

0.04%

Heavy metals

Not more than 20ppm

<20ppm

Assay(on the dried basis)

Not less than 98.5%

99.1%

 

4.Application 

Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 

Details

Poultry enrofloxacin

1. Basic information

Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine 

Appearance: Light-yellow or light-yellow orange crystalline powder

Purity: 99% min

2.Introduction 

Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

3.Specification 

Item

Standard

Result

Appearance

Light-yellow or light-yellow orange crystalline powder

Light-yellow crystalline Powder

Melting range

Between 221°C and 226°C

223.0°C~225.5°C

Identification

Meet the requirements

Meet the requirements

Fluoroquinolonic acid

Not more than 0.2%

<0.2%

Ciprofloxacin

Not more than 1.0%

0.15%

Loss on drying

Not more than 3.0%

0.1%

Residue on ignition

Not more than 0.2%

0.04%

Heavy metals

Not more than 20ppm

<20ppm

Assay(on the dried basis)

Not less than 98.5%

99.1%

 

4.Application 

Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.